{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:13:01Z","timestamp":1774332781422,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["FSEG-2023-0014"],"award-info":[{"award-number":["FSEG-2023-0014"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017638","name":"Ministry of Health of the Russian Federation","doi-asserted-by":"publisher","award":["TVKQ-2024-0006"],"award-info":[{"award-number":["TVKQ-2024-0006"]}],"id":[{"id":"10.13039\/501100017638","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijantimicag.2025.107491","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T16:44:34Z","timestamp":1741711474000},"page":"107491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the protective role of recombinant type III interferons in respiratory infections: Insights from an Mx1-deficient mouse model"],"prefix":"10.1016","volume":"66","author":[{"given":"A.","family":"Lozhkov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Dobrovolskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Romanovskaya-Romanko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6377-7445","authenticated-orcid":false,"given":"S.","family":"Shishlyannikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Elpaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garshinina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2012-9461","authenticated-orcid":false,"given":"Y.","family":"Zabrodskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Shaldzhyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Egorov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vasin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2025.107491_bib0001","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1159\/000360084","article-title":"Interferon-\u03bb in the context of viral infections: production, response and therapeutic implications","volume":"6","author":"Hermant","year":"2014","journal-title":"J Innate Immun"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.735576","article-title":"Interferon lambda signaling in macrophages is necessary for the antiviral response to influenza","volume":"12","author":"Mallampalli","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2014.51","article-title":"The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections","volume":"3","author":"Egli","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0004","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2015.07.001","article-title":"Interferon-\u03bb: immune functions at barrier surfaces and beyond","volume":"43","author":"Lazear","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0005","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2017.04.025","article-title":"Interferon-\u03bb mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness","volume":"46","author":"Galani","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0006","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s13238-017-0503-6","article-title":"IFN-\u03bb: a new spotlight in innate immunity against influenza virus infection","volume":"9","author":"Sun","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0007","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1128\/JVI.01213-12","article-title":"Critical role of MDA5 in the interferon response induced by Human metapneumovirus infection in dendritic cells and In vivo","volume":"87","author":"Banos-Lara","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0008","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/JVI.02897-14","article-title":"Impact and regulation of Lambda interferon response in Human metapneumovirus infection","volume":"89","author":"Ba\u00f1os-Lara","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0009","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00705-018-4087-0","article-title":"Both type I and type III interferons are required to restrict measles virus growth in lung epithelial cells","volume":"164","author":"Taniguchi","year":"2019","journal-title":"Arch Virol"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0010","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1089\/jir.2014.0083","article-title":"Antiviral effect of interferon Lambda against lymphocytic choriomeningitis virus","volume":"35","author":"Lukacikova","year":"2015","journal-title":"Journal of Interferon & Cytokine Research"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0011","doi-asserted-by":"crossref","first-page":"24530","DOI":"10.1038\/srep24530","article-title":"Dengue virus infection induces interferon-lambda1 to facilitate cell migration","volume":"6","author":"Hsu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0012","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12985-015-0383-4","article-title":"Interferon lambda inhibits dengue virus replication in epithelial cells","volume":"12","author":"Palma-Ocampo","year":"2015","journal-title":"Virol J"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0013","first-page":"269","article-title":"Interferon-\u03bb cures persistent murine norovirus infection in the absence of adaptive immunity","volume":"347","author":"Nice","year":"2015","journal-title":"Science (1979)"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0014","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm1462","article-title":"Role of deficient type III interferon-\u03bb production in asthma exacerbations","volume":"12","author":"Contoli","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0015","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/emmm.201100142","article-title":"IL-28A (IFN-\u03bb2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease","volume":"3","author":"Koltsida","year":"2011","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0016","doi-asserted-by":"crossref","first-page":"e33354","DOI":"10.7554\/eLife.33354","article-title":"IFN-\u03bb prevents influenza virus spread from the upper airways to the lungs and limits virus transmission","volume":"7","author":"Klinkhammer","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0017","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.15252\/emmm.201606413","article-title":"IFN \u03bb is a potent anti-influenza therapeutic without the inflammatory side effects of IFN \u03b1 treatment","volume":"8","author":"Davidson","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2014.07.022","article-title":"A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection","volume":"61","author":"Muir","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0019","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.coi.2015.12.002","article-title":"Host genetics of severe influenza: from mouse Mx1 to human IRF7","volume":"38","author":"Ciancanelli","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0020","doi-asserted-by":"crossref","DOI":"10.1007\/s00439-019-02092-8","article-title":"Mx genes: host determinants controlling influenza virus infection and trans-species transmission","volume":"139","author":"Haller","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0021","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00712-11","article-title":"The viral nucleoprotein determines mx sensitivity of influenza A viruses","volume":"85","author":"Zimmermann","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0022","doi-asserted-by":"crossref","DOI":"10.1038\/nri.2016.44","article-title":"Antiviral responses of inbred mice","volume":"16","author":"Iwasaki","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0023","first-page":"4518","article-title":"Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation","volume":"8","author":"Staeheli","year":"1988","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0024","first-page":"712","article-title":"Type I and III interferons disrupt lung epithelial repair during recovery from viral infection","volume":"369","author":"Major","year":"2020","journal-title":"Science (1979)"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0025","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3390\/pathogens9120989","article-title":"The key roles of interferon lambda in Human molecular defense against Respiratory viral infections","volume":"9","author":"Lozhkov","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0026","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00114-19","article-title":"Interferon lambda inhibits bacterial uptake during influenza superinfection","volume":"87","author":"Rich","year":"2019","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.procbio.2021.08.029","article-title":"Clean and folded: production of active, high quality recombinant human interferon-\u03bb1","volume":"111","author":"Shaldzhyan","year":"2021","journal-title":"Process Biochemistry"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0028","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/gene.2008.87","article-title":"Human interferon-\u03bb3 is a potent member of the type III interferon family","volume":"10","author":"Dellgren","year":"2009","journal-title":"Genes Immun"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0029","first-page":"163","article-title":"Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes","volume":"10","author":"Yu","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0030","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/jir.2018.0066","article-title":"Species specificity of type III interferon activity and development of a sensitive luciferase-based bioassay for quantitation of mouse interferon-\u03bb","volume":"38","author":"Jacobs","year":"2018","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0031","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.aaa1578","article-title":"Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency","volume":"348","author":"Ciancanelli","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0032","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01939-15","article-title":"Lambda interferon restructures the nasal microbiome and increases susceptibility to Staphylococcus aureus superinfection","volume":"7","author":"Planet","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0033","article-title":"Type III interferons disrupt the lung epithelial barrier upon viral recognition","volume":"369","author":"Broggi","year":"2020","journal-title":"Science (1979)"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdsr.2023.12.006","article-title":"Respiratory tract barrier dysfunction in viral-bacterial co-infection cases","volume":"60","author":"Sumitomo","year":"2024","journal-title":"Jpn Dent Sci Rev"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0035","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01305-15","article-title":"Protection from severe influenza virus infections in mice carrying the Mx1 influenza virus resistance gene strongly depends on genetic background","volume":"89","author":"Shin","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0036","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01116-07","article-title":"The Mx1 gene protects mice against the Pandemic 1918 and highly lethal Human H5N1 influenza viruses","volume":"81","author":"Tumpey","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0037","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.06156-11","article-title":"Molecular signatures associated with Mx1-mediated resistance to highly pathogenic influenza virus infection: mechanisms of survival","volume":"86","author":"Cilloniz","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2025.107491_bib0038","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1038\/ncomms4864","article-title":"Pathogenic potential of interferon \u03b1\u03b2 in acute influenza infection","volume":"5","author":"Davidson","year":"2014","journal-title":"Nat Commun"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925000482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925000482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T14:55:09Z","timestamp":1746543309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857925000482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0924857925000482"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107491","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the protective role of recombinant type III interferons in respiratory infections: Insights from an Mx1-deficient mouse model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107491","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107491"}}